Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis

BACKGROUND: Nadroparin is used during hemodialysis to prevent clotting of the extra corporeal system. During nocturnal hemodialysis patients receive an increased dosage of nadroparin compared to conventional hemodialysis. We tested whether the prescribed dosage regimen of nadroparin, according to Du...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BBA Clin
Hlavní autoři: Buitenwerf, Edward, Risselada, Arne J., van Roon, Eric N., Veeger, Nic J.G.M., Hemmelder, Marc H.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2015
Témata:
Regular Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4661578/
https://ncbi.nlm.nih.gov/pubmed/26672512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbacli.2015.03.006
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky